Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 0904-7372

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 0904-7372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

360mg Carton Label (6b170816 6e5c 400c B97b 82bbbb7d4925 00)

This is a description of Mycophenolic Acid Delayed-Release Tablets, USP in a unit dose packaging containing 100 tablets. The tablets contain 360 mg of mycophenolic acid per delayed-release tablet. The product should be stored at room temperature and protected from moisture in a tight container. It is essential to refer to the product insert for prescribing information, precautions, and warnings. The tablets are to be dispensed with a Medication Guide. The medication is from NDC # 67877-427, Ascend Laboratories, LLC, and distributed by Major Pharmaceuticals in Indianapolis, USA. The package contains 10 blister cards with 10 tablets each.*

FDA Label Image

Myco-str (Mycophenolicacid Str 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.